Seth Porter
16Patents
12h-index
10Co-inventors
75Inventor score
Filing activity: Sep 4, 1990 → Jul 5, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8389578B2 | Composition and method for treating neurological disease | Human Necessities | 97 | Active |
| US8168209B2 | Method and composition for administering an NMDA receptor antagonist to a subject | Human Necessities | 33 | Active |
| US5260210A | Blood-brain barrier model | Chemistry; Metallurgy | 28 | Expired |
| US8796337B2 | Composition and method for treating neurological disease | Human Necessities | 27 | Active |
| US8895615B1 | Composition and method for treating neurological disease | Human Necessities | 21 | Active |
| US8895618B1 | Composition and method for treating neurological disease | Human Necessities | 21 | Active |
| US8895617B1 | Composition and method for treating neurological disease | Human Necessities | 21 | Active |
| US8895616B1 | Composition and method for treating neurological disease | Human Necessities | 21 | Active |
| US8889740B1 | Composition and method for treating neurological disease | Human Necessities | 21 | Active |
| US8895614B2 | Composition and method for treating neurological disease | Human Necessities | 21 | Active |
| US8987333B2 | Composition and method for treating neurological disease | Human Necessities | 20 | Active |
| US8426472B2 | Method and composition for administering an NMDA receptor antagonist to a subject | Human Necessities | 20 | Active |
| US10039515B2 | Methods for treating idiopathic pulmonary fibrosis | Human Necessities | 2 | Active |
| US9102721B2 | Therapeutic method | Human Necessities | 1 | Active |
| US9480449B2 | Methods for treating idiopathic pulmonary fibrosis | Human Necessities | 0 | Active |
| US10555713B2 | Methods for treating idiopathic pulmonary fibrosis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.